LD

LSP Dementia Fund

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

LSP Dementia Fund is a venture capital fund managed by Life Sciences Partners.

Investor Profile

LSP Dementia Fund has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Post Ipo Equity, Series B rounds (top funding stages).
  • Majority of deals are located in Belgium, The Netherlands, United States.
  • Strong thematic focus on Biotechnology, Artificial Intelligence (AI), Life Science.

Stage Focus

  • Series Unknown (33%)
  • Post Ipo Equity (33%)
  • Series B (33%)

Country Focus

  • Belgium (33%)
  • The Netherlands (33%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Life Science
  • Pharmaceutical
  • Genetics
  • Health Care
  • Precision Medicine
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LSP Dementia Fund frequently co-invest with?

BNP Paribas Fortis
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
MV
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Medicxi
Europe, England, United Kingdom, London
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
LH
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
GC
North America, Georgia, United States, Atlanta
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1

What are some of recent deals done by LSP Dementia Fund?

QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Post Ipo EquityNov 23, 2022
Amount Raised: $235,000,000
Nobi

Antwerpen, Antwerpen, Belgium

Nobi is an AI-powered smart lamp.

Artificial Intelligence (AI)
Series UnknownJan 28, 2022
Amount Raised: $14,494,224

Find More Investors Like LSP Dementia Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

LSP Dementia Fund | Pipeseed